Ortin Laboratories Limited Share Price NSE India S.E.
Equities
ORTINLAB
INE749B01020
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.3 INR | +0.78% | -3.50% | -16.45% |
17/02 | Ortin Laboratories Limited Announces Board Appointments | CI |
13/02 | Ortin Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Sales 2022 | 82.31M 987K | Sales 2023 | 60.2M 722K | Capitalization | 141M 1.7M |
---|---|---|---|---|---|
Net income 2022 | -3M -35.99K | Net income 2023 | - 0 | EV / Sales 2022 | 2.92 x |
Net Debt 2022 | 56.52M 678K | Net Debt 2023 | 62.27M 747K | EV / Sales 2023 | 3.38 x |
P/E ratio 2022 |
-46.1
x | P/E ratio 2023 |
-145
x | Employees | 24 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.93% |
1 day | +0.78% | ||
1 week | -3.50% | ||
Current month | -2.28% | ||
1 month | -8.10% | ||
3 months | -11.67% | ||
6 months | +8.73% | ||
Current year | -16.45% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | 58 | 29/08/29 | |
Divya Purswani
CMP | Compliance Officer | - | 09/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 58 | 29/08/29 | |
Chief Executive Officer | - | - | |
Director/Board Member | 61 | 29/08/29 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 19.3 | +0.78% | 11,021 |
02/24/02 | 19.15 | -3.04% | 33,521 |
30/24/30 | 19.75 | 0.00% | 12,195 |
29/24/29 | 19.75 | -1.25% | 20,355 |
Delayed Quote NSE India S.E., May 03, 2024 at 05:13 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- ORTINLAB Stock
- ORTINLAB Stock